GCWM
AEON icon

Graham Capital Wealth Management’s AEON Biopharma AEON Stock Holding History

Graham Capital Wealth Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-136
Closed -$997K – 47
2023
Q1 		$997K Sell
136
-211
-61% -$153K 0.14% 72
2022
Q4 		$251K Buy
+347
New +$249K 0.45% 39

Other funds holding AEON

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Graham Capital Wealth Management's AEON Position: Q2 2023 in Review

Graham Capital Wealth Management sold out of AEON Biopharma (AEON) in Q2 2023, closing a stake of 136 shares — an estimated $997K sold.

Graham Capital Wealth Management first reported a position in AEON in Q4 2022 and held it in 2 quarters. The position peaked at $997K in Q1 2023. 17 funds tracked by Wall St. Rank hold AEON as of Q2 2023.

  • Graham Capital Wealth Management reported no remaining AEON Biopharma position as of Q2 2023 after selling out during the quarter.
  • Graham Capital Wealth Management sold 136 AEON Biopharma shares in Q2 2023, an estimated $997K.
  • Graham Capital Wealth Management first reported a position in AEON Biopharma in Q4 2022 and held it in 2 quarters.
  • Graham Capital Wealth Management's AEON Biopharma position peaked at $997K in Q1 2023.
  • 17 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2023.

Based on Graham Capital Wealth Management's 13F filing for Q2 2023, filed 25 Jul 2023.